ENANTA PHARMACEUTICALS INC - Common Stock (ENTA)

CUSIP: 29251M106

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common Stock
Shares outstanding
28,862,345
Total 13F shares
13,334,548
Share change
+225,989
Total reported value
$446,581,457
Put/Call ratio
0%
Price per share
$33.50
Number of holders
146
Value change
+$14,267,822
Number of buys
79
Number of sells
52

Security key

29251M106

Report period

Q4 2016

Institutions

146

Top holders

10

Top shareholders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Fund Advisors
13F
Company
4.5%
1,293,604
$34,423,000 30 Sep 2016
13F
Krensavage Asset Management, LLC
13F
Company
3.5%
999,741
$26,603,000 30 Sep 2016
13F
GREAT POINT PARTNERS LLC
13F
Company
2.7%
790,000
$21,022,000 30 Sep 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.4%
701,400
$18,664,000 30 Sep 2016
13F
VANGUARD GROUP INC
13F
Company
2.4%
696,877
$18,543,000 30 Sep 2016
13F
SENZAR ASSET MANAGEMENT, LLC
13F
Company
1.8%
506,900
$13,488,609 30 Sep 2016
13F
Granahan Investment Management, LLC
13F
Company
1.6%
471,135
$12,537,000 30 Sep 2016
13F
FMR LLC
13F
Company
1.4%
411,815
$10,958,000 30 Sep 2016
13F
AJO, LP
13F
Company
1.4%
406,265
$10,811,000 30 Sep 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
1.4%
390,688
$10,396,000 30 Sep 2016
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.3%
369,297
$9,828,000 30 Sep 2016
13F
STATE STREET CORP
13F
Company
1.1%
331,367
$8,818,000 30 Sep 2016
13F
Spark Investment Management LLC
13F
Company
1.1%
318,500
$8,475,000 30 Sep 2016
13F
Ghost Tree Capital, LLC
13F
Company
0.87%
250,000
$6,653,000 30 Sep 2016
13F
Matarin Capital Management, LLC
13F
Company
0.86%
246,848
$6,568,626 30 Sep 2016
13F
S.c.a. Candriam
13F
Individual
0.84%
242,000
$6,440,000 30 Sep 2016
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.73%
212,000
$5,641,000 30 Sep 2016
13F
Bank of New York Mellon Corp
13F
Company
0.66%
191,156
$5,087,000 30 Sep 2016
13F
McClain Value Management LLC
13F
Company
0.63%
183,086
$4,872,000 30 Sep 2016
13F
NORTHERN TRUST CORP
13F
Company
0.63%
182,817
$4,864,000 30 Sep 2016
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.6%
173,300
$4,611,000 30 Sep 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.59%
169,227
$4,501,000 30 Sep 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.56%
162,118
$4,314,000 30 Sep 2016
13F
HAYS ADVISORY LLC
13F
Company
0.54%
156,547
$4,166,000 30 Sep 2016
13F
SEIZERT CAPITAL PARTNERS, LLC
13F
Company
0.53%
152,190
$4,050,000 30 Sep 2016
13F
Numeric Investors LLC
13F
Company
0.52%
149,900
$3,989,000 30 Sep 2016
13F
JPMORGAN CHASE & CO
13F
Company
0.48%
138,975
$3,698,000 30 Sep 2016
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.48%
137,752
$3,666,000 30 Sep 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.47%
136,630
$3,636,000 30 Sep 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.44%
126,148
$3,356,000 30 Sep 2016
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.37%
107,965
$2,873,000 30 Sep 2016
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.36%
103,817
$2,763,000 30 Sep 2016
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.35%
101,178
$2,692,000 30 Sep 2016
13F
QS Investors, LLC
13F
Company
0.32%
91,016
$2,422,000 30 Sep 2016
13F
D. E. Shaw & Co., Inc.
13F
Company
0.3%
87,339
$2,324,000 30 Sep 2016
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.28%
81,740
$2,175,000 30 Sep 2016
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.28%
81,404
$2,166,000 30 Sep 2016
13F
BAKER BROS. ADVISORS LP
13F
Company
0.26%
75,357
$2,005,000 30 Sep 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.25%
72,626
$1,933,000 30 Sep 2016
13F
Gotham Asset Management, LLC
13F
Company
0.24%
68,514
$1,823,000 30 Sep 2016
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.23%
67,348
$1,792,000 30 Sep 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.22%
63,315
$1,685,000 30 Sep 2016
13F
SECOR Capital Advisors, LP
13F
Company
0.2%
58,620
$1,560,000 30 Sep 2016
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.18%
51,200
$1,362,000 30 Sep 2016
13F
Invesco Ltd.
13F
Company
0.17%
50,433
$1,342,000 30 Sep 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.17%
48,112
$1,281,000 30 Sep 2016
13F
Freedom Investment Management, Inc.
13F
Company
0.16%
44,871
$1,194,000 30 Sep 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.15%
44,464
$1,183,000 30 Sep 2016
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.15%
43,962
$1,170,000 30 Sep 2016
13F
Asset Management One Co., Ltd.
13F
Company
0.15%
43,575
$1,160,000 30 Sep 2016
13F

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) as of Q4 2016

As of 31 Dec 2016, ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) was held by 146 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,334,548 shares. The largest 10 holders included BlackRock Fund Advisors, Krensavage Asset Management, LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, FIRST MANHATTAN CO, and BlackRock Institutional Trust Company, N.A.. This page lists 146 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
133
Q4 2016 holders
146
Holder diff
13
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 Value $ Q4 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .